0001562180-21-007025.txt : 20211112 0001562180-21-007025.hdr.sgml : 20211112 20211112172409 ACCESSION NUMBER: 0001562180-21-007025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211109 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russell Alan J CENTRAL INDEX KEY: 0001853529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 211404972 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE CITY: BOULDER STATE: CO ZIP: 80303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 303-735-8373 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE. CITY: BOULDER STATE: CO ZIP: 80303 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-11-09 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001853529 Russell Alan J C/O EDGEWISE THERAPEUTICS, INC. 3145 COLORADO AVE. BOULDER CO 80303 true true false false Chief Scientific Officer Common Stock 2021-11-09 2021-11-09 4 S false 16864.00 19.9404 D 53355.00 D Common Stock 2021-11-09 2021-11-09 4 S false 12712.00 20.2982 D 40643.00 D Common Stock 2021-11-10 2021-11-10 4 S false 11746.00 19.7043 D 28897.00 D Common Stock 2021-11-10 2021-11-10 4 S false 580.00 20.2122 D 28317.00 D Common Stock 2021-11-11 2021-11-11 4 S false 15595.00 19.8168 D 12722.00 D Common Stock 2021-11-11 2021-11-11 4 S false 3681.00 20.428 D 9041.00 D Common Stock 2021-11-12 2021-11-12 4 S false 8562.00 19.5134 D 479.00 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on June 17, 2021. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.17 to $20.165, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.17 to $20.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.095 to $20.05, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.16 to $20.35, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.29 to $20.285, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $20.29 to $20.82, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John R. Moore, Attorney-in-Fact for Russell Alan J 2021-11-12